PortfoliosLab logoPortfoliosLab logo
Longeveron Inc. (LGVN)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US54303L1044
CUSIP
54303L104
IPO Date
Feb 12, 2021

Highlights

EPS (TTM)
-$1.28
Total Revenue (TTM)
$1.44M
Gross Profit (TTM)
$1.08M
EBITDA (TTM)
-$20.52M
Year Range
$0.48 - $1.83
Target Price
$10.00
ROA (TTM)
-207.98%
ROE (TTM)
-376.05%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Longeveron Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Longeveron Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Longeveron Inc. (LGVN) has returned 105.53% so far this year and -32.90% over the past 12 months.


Longeveron Inc.

1D
11.78%
1M
92.09%
YTD
105.53%
6M
38.65%
1Y
-32.90%
3Y*
-66.10%
5Y*
-56.25%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Feb 12, 2021, LGVN's average daily return is +0.12%, while the average monthly return is +5.36%. At this rate, your investment would double in approximately 1.1 years.

Historically, 35% of months were positive and 65% were negative. The best month was Nov 2021 with a return of +661.2%, while the worst month was Jan 2024 at -60.4%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 11 months.

On a daily basis, LGVN closed higher 42% of trading days. The best single day was Nov 22, 2021 with a return of +181.2%, while the worst single day was Aug 8, 2025 at -46.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202610.61%-3.27%92.09%105.53%
2025-10.98%-1.30%1.97%8.39%-26.19%4.84%24.62%-48.88%-9.42%11.16%-20.40%-23.76%-70.75%
2024-60.37%-0.93%-39.14%-47.38%-35.67%46.36%94.41%-34.82%-4.90%7.73%-1.91%-15.61%-87.28%
202325.47%-11.39%-25.42%8.24%2.42%14.19%-2.07%-15.11%-16.73%-15.81%-0.51%-30.61%-57.76%
2022-38.11%-9.50%104.14%-27.39%-18.46%-27.42%5.06%-23.19%-22.68%-2.16%7.18%-17.01%-73.32%
20217.96%-17.62%-6.68%7.32%23.18%-29.40%-39.37%1.44%-2.27%661.16%-54.04%62.89%

Benchmark Metrics

Longeveron Inc. has an annualized alpha of 19.16%, beta of 1.19, and R² of 0.01 versus S&P 500 Index. Calculated based on daily prices since February 16, 2021.

  • This stock participated in 86.79% of S&P 500 Index downside but only -122.77% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.01 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
19.16%
Beta
1.19
0.01
Upside Capture
-122.77%
Downside Capture
86.79%

Return for Risk

Risk / Return Rank

LGVN ranks 32 for risk / return — below 32% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


LGVN Risk / Return Rank: 3232
Overall Rank
LGVN Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
LGVN Sortino Ratio Rank: 3939
Sortino Ratio Rank
LGVN Omega Ratio Rank: 3939
Omega Ratio Rank
LGVN Calmar Ratio Rank: 2525
Calmar Ratio Rank
LGVN Martin Ratio Rank: 2929
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Longeveron Inc. (LGVN) and compare them to a chosen benchmark (S&P 500 Index).


LGVNBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.28

0.90

-1.17

Sortino ratio

Return per unit of downside risk

0.40

1.39

-0.99

Omega ratio

Gain probability vs. loss probability

1.05

1.21

-0.16

Calmar ratio

Return relative to maximum drawdown

-0.47

1.40

-1.87

Martin ratio

Return relative to average drawdown

-0.69

6.61

-7.30

Explore LGVN risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Longeveron Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Longeveron Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Longeveron Inc. was 99.89%, occurring on Mar 6, 2026. The portfolio has not yet recovered.

The current Longeveron Inc. drawdown is 99.75%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.89%Nov 26, 20211072Mar 6, 2026
-65.44%Mar 12, 2021175Nov 17, 20212Nov 19, 2021177
-38.94%Nov 23, 20211Nov 23, 20211Nov 24, 20212
-17.98%Feb 17, 20213Feb 19, 20213Feb 24, 20216
-16.61%Mar 3, 20213Mar 5, 20214Mar 11, 20217

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Longeveron Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Longeveron Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for LGVN relative to other companies in the Biotechnology industry. Currently, LGVN has a P/S ratio of 12.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items